West Pharmaceutical Services | WST - Selling And Administration Expenses


West Pharmaceutical Services reported $99.5M in Selling and Administration Expenses for its fiscal quarter ending in March of 2026.





Selling And Administration Expenses Change Date
Align Technology USD 465.34M 23.67M Mar/2026
Avanos Medical USD 77.7M 1.1M Mar/2026
Baxter International USD 728M 33M Mar/2026
Becton, Dickinson and Co. USD 1.21B 180M Mar/2026
Cerus USD 19.33M 1.55M Dec/2024
Charles River Laboratories USD 159.42M 36.71M Mar/2026
Cooper Companies USD 676.2M 303.1M Mar/2026
Dentsply International USD 351M 32M Mar/2026
Haemonetics USD 109.15M 7.54M Dec/2025
ICU Medical USD 155.81M 3.04M Dec/2025
Insulet USD 317.2M 14.2M Mar/2026
Integra LifeSciences USD 178.24M 21.79M Mar/2026
IQVIA Holdings USD 502M 34M Mar/2026
J&J USD 6.03B 719M Mar/2026
Medtronic 2.96B 9M Dec/2025
Merit Medical Systems USD 110.47M 4.36M Mar/2026
Neogen USD 98.5M 9M Dec/2025
OraSure Technologies USD 13.21M 3.29M Dec/2025
Quidel USD 199.3M 4.9M Mar/2026
Repligen USD 76.54M 2.17M Mar/2026
Rockwell Medical USD 4.04M 330K Jun/2024
Solventum Corp USD 783M 24M Mar/2026
STAAR Surgical USD 38.64M 299K Mar/2026
Terumo JPY 114.81B 9.55B Mar/2026
Utah Medical Products USD 2.61M 741K Dec/2025
West Pharmaceutical Services USD 99.5M 7M Mar/2026